Our assessment
HealthSource does two things almost nobody else here does. It commits in writing to all fifty states on its own service-areas page, and it prints the billing cycle on the price itself instead of calling everything monthly. It also says outright that it will not publish who its practitioners are, and it hides every figure behind a variant selector, so the catalog view shows a floor and nothing more.
Four weeks and eight weeks, not months
Each product page prices a supply cycle. The full-dose option renews every four weeks; a longer option renews every eight. The page says so in the price line itself.
That is more honest than the alternative, and it matters over a year. A four-week cycle bills thirteen times, not twelve. None of these figures is a monthly rate, and turning one into a monthly rate would invent a number HealthSource never published.
There is a wrinkle. The starter-dose variants display the same price as the full-dose option, even though one of them says it covers a six-week supply. The page does not explain that.
You have to click to see a price
On load, the product page shows a dropdown labeled Initial Supply and no figure at all. A price appears only once you select an option. The catalog and the related-products strip show a From figure instead.
So comparing HealthSource against anything means opening each product and working through the selector one option at a time.
An oral tirzepatide lane with its own price
Alongside the two injectable programs sits an oral tirzepatide product with its own published cycle price. Very few sellers here price an oral dual-agonist at all, and fewer still give it a page of its own.
All three are described as prepared by a partner 503A pharmacy, which is never named.
It says it will not name its practitioners
The medical-practitioners page names the physician network that issues every prescription, describes its coverage and links to it, then says plainly that the company does not publicly list individual practitioners.
The only doctor named on that page is the chief executive of the partner network, described as licensed in a number of states. That tells you about the network’s leadership, not about who will write your prescription.
The service-areas page is the opposite case. There the company speaks about its own operations: all fifty states including Alaska and Hawaii, with US territories and international patients excluded.
HealthSource's published pricing
Prices re-verified September 2026
| Medication | Price |
|---|---|
| MedicationSemaglutide (compounded) — full dose, four-week supply | Price$199per 4-week billing cycle, not a calendar month — the starter-dose options show the same figure. |
| MedicationSemaglutide (compounded) — eight-week supply | Price$349per 8-week supply, as published — not broken into a monthly rate. |
| MedicationTirzepatide (compounded) — full dose, four-week supply | Price$299per 4-week billing cycle, not a calendar month — the starter-dose options show the same figure. |
| MedicationTirzepatide (compounded) — eight-week supply | Price$549per 8-week supply, as published — not broken into a monthly rate. |
| MedicationTirzepatide (compounded-oral) — oral, full dose, four-week supply | Price$399per 4-week billing cycle, not a calendar month — the starter-dose option shows the same figure. |
Compare GLP may earn a commission when a reader signs up with a provider through a link on this site. 28 of the 420 providers reviewed here are paid partners today; the other 392 are not. See how this works.
See HealthSource's current price →Who HealthSource suits
Good fit if
- Readers who want a written all-fifty-states commitment on the seller’s own page.
- Buyers who want to know the actual billing interval rather than a figure labeled monthly.
- People looking for an oral dual-agonist lane with a published price.
Look elsewhere if
- Anyone who wants to know which clinician will treat them, since the site says it will not list them.
- Buyers who want the compounding pharmacy named.
- Readers who want to compare prices without clicking through a variant selector on every product.
What stands out about HealthSource
Strengths
- Its service-areas page commits to all 50 states, names Alaska and Hawaii explicitly, and says it serves no US territories
- States the billing cycle on the price itself — every four weeks, every eight weeks — rather than calling everything monthly
- Offers an oral tirzepatide lane with its own published price, which very little on this comparison does
- Names the physician network that issues every prescription and links to it
Trade-offs
- Says in as many words that it does not publicly list individual practitioners; the only doctor named on the site is the chief executive of its partner network, not a prescriber it employs
- The partner 503A pharmacy is never named
- Prices are only visible after a variant is selected on the product page, so a reader scanning the catalog sees a From figure and nothing else
- Whether a separate program or membership fee applies is never stated
How this review was verified
- Three product pages, the service-areas page and the medical-practitioners page read.
- Every price line states its billing cycle: every four weeks, or every eight weeks. None of them states a month.
- The all-fifty-states statement is on the seller’s own service-areas page. The physician network's chief executive is the only doctor named, and that is the partner's leadership rather than a prescriber.
Where HealthSource ranks
HealthSource qualifies for 5 of the 6 boards on this site. A board only ranks the providers that meet its own condition, so a missing board means HealthSource does not publish what that board sorts on.
- Semaglutide — #221 of 334
- Tirzepatide — #210 of 319
- Cheapest Overall — #250 of 396
- Oral — #76 of 108
- Cash Pay vs Insurance — #72 of 80
Compare HealthSource directly
Compare GLP may earn a commission when a reader signs up with a provider through a link on this site. 28 of the 420 providers reviewed here are paid partners today; the other 392 are not. See how this works.
| Provider | Score | From/mo | Full review | Action |
|---|---|---|---|---|
| Belle Health | 10.0/10 | From/mo$109Advertised monthly equivalent for a twelve-month supply; not a verified monthly installment. Six-month rate $119, two-month rate $135, one-month rate $199. Confirm the upfront payment and refill schedule. | Full reviewRead the Belle Health review | Visit |
| Midi Health | 10.0/10 | From/mo$164for a 4-week supply, the lowest of four published dose tiers, including shipping | Full reviewRead the Midi Health review | Visit |
| altRx | 8.6/10 | From/mo$89/moadvertised monthly starting price for a multi-dose vial; confirm plan length and checkout total | Full reviewRead the altRx review | Visit |
Frequently asked questions
Is the price monthly?
No. The pages price a four-week or eight-week supply cycle and say so in the price line.
Why does the catalog show no price?
Each product page shows a figure only after you select an option in its Initial Supply dropdown.
Which states does it serve?
Its service-areas page commits to all fifty states, names Alaska and Hawaii, and excludes US territories and international patients.
Who prescribes?
Clinicians at a named physician network. The site states it does not publicly list individual practitioners.
Which pharmacy fills the prescription?
Not named. The pages describe a partner 503A pharmacy.
Is there a membership fee?
Not stated. The pages describe a recurring subscription with a monthly reassessment and an auto-refund if it is not completed.
Ready to compare directly?
HealthSource scores 4.3/10 on this site's rubric. Review the published prices and their conditions above, then confirm your total with the provider. Visiting its site does not commit you to treatment.
Compare GLP may earn a commission when a reader signs up with a provider through a link on this site. 28 of the 420 providers reviewed here are paid partners today; the other 392 are not. See how this works.
Visit HealthSource →